As an independent, non-governmental, non-profit cancer research Organisation established under the laws of Belgium, its mission is to coordinate and conduct international translational and clinical research to improve the standard of cancer treatment for patients.
EORTC aims ultimately to increase people’s survival and quality of life by testing new therapeutic strategies based on existing drugs, surgery, and radiotherapy. EORTC also helps develop new drugs and approaches in partnership with the pharmaceutical industry and in patients’ best interests.
In addition to independence, EORTC is recognised for scientific and methodological rigor bringing robust datasets to doctors and patients for therapeutic improvement. EORTC covers all disciplines to fight against cancer. EORTC research leaves no one behind and addresses all patients, including patients with rare tumours and specific patient populations.
EORTC is unique:
- International: EORTC manages clinical research activities across more than 35 countries.
- Multidisciplinary: our research spans all aspects of cancer management, from imaging and radiology to surgery and therapeutic innovations, backed by cutting-edge expertise in all fields.
- Multi-tumour: thanks to our broad-ranging network of oncology experts, no tumour is too rare to tackle. Our research is solution-driven, for all types of cancers, leaving no one behind.
- Compliant with regulation: in today’s complex regulatory environment, EORTC’s experts ensure our activities meet the strictest quality and reliability requirements, everywhere EORTC is active.
- Independent: our research is conducted under conditions of unwavering independence and accountability and all results are made public, to ensure patients and the oncology community benefit from our learnings.